InnoCare Pharma News

Nuocheng Jianhua: Hong Kong Stock Announcement: List of Directors and Their Roles and Functions

Sep 26 00:00

Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the Board of Directors Special Committee

Sep 26 00:00

Hong Kong Stock Announcement: List of Directors and Their Roles and Functions

Sep 26 00:00

Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the special committee of the board

Sep 26 00:00

Hong Kong Stock Announcement: 2024 Interim Report

Sep 25 00:00

Announcement of Nuocheng Jianhua Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision

Sep 21 00:00

China International Finance Corporation\'s inspection opinions on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd.\'s strategic placement and listing circulation of restricted shares

Sep 11 00:00

Announcement on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd., the listing and circulation of restricted shares

Sep 11 00:00

Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the progress of clinical trials of obutinib

Sep 9 00:00

Hong Kong Stock Announcement: Monthly Statement of Changes in Securities

Sep 5 00:00

China International Finance Corporation\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Nuochengjianhua Pharmaceutical Co., Ltd.

Sep 5 00:00

Hong Kong Stock Announcement: Next Day Disclosure Statement

Aug 31 00:00

Special report on the use of funds raised in the first half of 2024 by Innocare Pharmaceutical Co., Ltd.

Aug 21 00:00

Innocare Pharmaceuticals Co., Ltd. 2024 Half-year Report

Aug 21 00:00

InnoCare Pharma: Announcement of midterm performance for the six months ending on June 30, 2024.

Aug 21 00:00

Summary of the 2024 semi-annual report of innocare Pharmaceuticals Co., Ltd.

Aug 21 00:00

Announcement from Innocare Pharmaceuticals Co., Ltd. on the 2024 mid-year performance briefing.

Aug 14 00:00

InnoCare Pharma: Board of directors meeting date.

Aug 8 00:00

InnoCare Pharma: Monthly securities change report.

Aug 6 00:00

Innocare Pharmaceutical voluntarily discloses the announcement of the first dosing of ICP-332 trial subjects in the United States.

Jul 25 00:00